Humira, Rituxan top list of U.S. costliest drug price increases - report

AbbVie Inc's arthritis drug Humira and Roche Holding AG's cancer drug Rituxan top the list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a report released on Tuesday showed.

from Reuters: Health News https://ift.tt/2APke8F